The Potential for Clinical Dependence and Withdrawal Symptoms Associated With Valbenazine
Clinical trial NCT03698331 · COMPLETED
Trial details
- NCT number
- NCT03698331
- Sponsor
- Neurocrine Biosciences
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-14
- Primary completion
- 2019-04-03
- Enrollment
- 89
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.